The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell Lymphoma

Diffuse Large B-cell Lymphoma (DLBCL) is the most common aggressive non-Hodgkin lymphoma (NHL). Despite the use of newer agents, such as polatuzumab vedotin, more than one-third of patients have ultimately relapsed or experienced refractory disease. MiRNAs are single-stranded, ~22-nucleotide-long RN...

全面介紹

書目詳細資料

發表在:	Biomedicines
Main Authors:	Epameinondas Koumpis, Vasileios Georgoulis, Konstantina Papathanasiou, Alexandra Papoudou-Bai, Panagiotis Kanavaros, Evangelos Kolettas, Eleftheria Hatzimichael
格式:	Article
語言:	英语
出版:	MDPI AG 2024-11-01
主題:	lymphoma DLBCL miRNAs miR-155 biomarkers lymphomagenesis
在線閱讀:	https://www.mdpi.com/2227-9059/12/12/2658